CRIT REV ONCOL HEMAT 润色咨询

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

出版年份:1983 年文章数:1913 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:1.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1070637, encodeId=ddf910e063721, content=投稿命中率:25.0<br>经验分享:投稿第二天就显示under review ,是真的送审了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Tue Nov 16 08:24:15 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190139, encodeId=f2811190139c0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:实体肿瘤;Review;血液肿瘤<br>经验分享:一审一个月,大修一个半月,小修后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Fri Feb 04 13:51:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:血液;肿瘤;综述<br>经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,<br>2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。<br>终于在2023.09.12 accept。<br>总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=800917, encodeId=5ee580091e3a, content=审稿速度:6.0<br>偏重的研究方向:血液学<br>经验分享:审稿时间大概五个月,提了很多问题很详细,大修一个月,接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200702/284aa92a2ae34578ae5df1f807e3678b/43c408bf15664b3ba10dcb5b02244935.jpg, createdBy=b9431973006, createdName=怕种菜, createdTime=Thu Jul 02 18:05:59 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799445, encodeId=5f1ae99445a7, content=去年中了一篇,先大修再小修,审稿人非常nice,但是整个过程时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=784b2053516, createdName=Lynn0123, createdTime=Tue Jun 23 13:17:02 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor一个月、催稿两次,目前还没有消息,服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向:肿瘤<br>经验分享:12月15日投稿,到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向:肿瘤;胃癌<br>经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2119068, encodeId=38ec21190682d, content=偏重的研究方向:review<br>经验分享:投稿几天后With editor 变成 Decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/eaf6a670992538bfff9986e52fed6975.jpg, createdBy=10022477991, createdName=羽翼纷飞, createdTime=Sun Mar 12 13:44:11 CST 2023, time=2023-03-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1087157, encodeId=f839108e15788, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-11-16 capoex

    投稿命中率:25.0
    经验分享:投稿第二天就显示under review ,是真的送审了么

    12

    展开12条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1070637, encodeId=ddf910e063721, content=投稿命中率:25.0<br>经验分享:投稿第二天就显示under review ,是真的送审了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Tue Nov 16 08:24:15 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190139, encodeId=f2811190139c0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:实体肿瘤;Review;血液肿瘤<br>经验分享:一审一个月,大修一个半月,小修后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Fri Feb 04 13:51:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:血液;肿瘤;综述<br>经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,<br>2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。<br>终于在2023.09.12 accept。<br>总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=800917, encodeId=5ee580091e3a, content=审稿速度:6.0<br>偏重的研究方向:血液学<br>经验分享:审稿时间大概五个月,提了很多问题很详细,大修一个月,接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200702/284aa92a2ae34578ae5df1f807e3678b/43c408bf15664b3ba10dcb5b02244935.jpg, createdBy=b9431973006, createdName=怕种菜, createdTime=Thu Jul 02 18:05:59 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799445, encodeId=5f1ae99445a7, content=去年中了一篇,先大修再小修,审稿人非常nice,但是整个过程时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=784b2053516, createdName=Lynn0123, createdTime=Tue Jun 23 13:17:02 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor一个月、催稿两次,目前还没有消息,服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向:肿瘤<br>经验分享:12月15日投稿,到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向:肿瘤;胃癌<br>经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2119068, encodeId=38ec21190682d, content=偏重的研究方向:review<br>经验分享:投稿几天后With editor 变成 Decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/eaf6a670992538bfff9986e52fed6975.jpg, createdBy=10022477991, createdName=羽翼纷飞, createdTime=Sun Mar 12 13:44:11 CST 2023, time=2023-03-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1087157, encodeId=f839108e15788, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-02-04 capoex

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:实体肿瘤;Review;血液肿瘤
    经验分享:一审一个月,大修一个半月,小修后就接收了。

    6

    展开6条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1070637, encodeId=ddf910e063721, content=投稿命中率:25.0<br>经验分享:投稿第二天就显示under review ,是真的送审了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Tue Nov 16 08:24:15 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190139, encodeId=f2811190139c0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:实体肿瘤;Review;血液肿瘤<br>经验分享:一审一个月,大修一个半月,小修后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Fri Feb 04 13:51:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:血液;肿瘤;综述<br>经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,<br>2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。<br>终于在2023.09.12 accept。<br>总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=800917, encodeId=5ee580091e3a, content=审稿速度:6.0<br>偏重的研究方向:血液学<br>经验分享:审稿时间大概五个月,提了很多问题很详细,大修一个月,接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200702/284aa92a2ae34578ae5df1f807e3678b/43c408bf15664b3ba10dcb5b02244935.jpg, createdBy=b9431973006, createdName=怕种菜, createdTime=Thu Jul 02 18:05:59 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799445, encodeId=5f1ae99445a7, content=去年中了一篇,先大修再小修,审稿人非常nice,但是整个过程时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=784b2053516, createdName=Lynn0123, createdTime=Tue Jun 23 13:17:02 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor一个月、催稿两次,目前还没有消息,服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向:肿瘤<br>经验分享:12月15日投稿,到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向:肿瘤;胃癌<br>经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2119068, encodeId=38ec21190682d, content=偏重的研究方向:review<br>经验分享:投稿几天后With editor 变成 Decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/eaf6a670992538bfff9986e52fed6975.jpg, createdBy=10022477991, createdName=羽翼纷飞, createdTime=Sun Mar 12 13:44:11 CST 2023, time=2023-03-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1087157, encodeId=f839108e15788, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2023-09-13 气管支气管 来自江西省

    审稿速度:12.0 | 投稿命中率:50.0
    偏重的研究方向:血液;肿瘤;综述
    经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,
    2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。
    终于在2023.09.12 accept。
    总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1070637, encodeId=ddf910e063721, content=投稿命中率:25.0<br>经验分享:投稿第二天就显示under review ,是真的送审了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Tue Nov 16 08:24:15 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190139, encodeId=f2811190139c0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:实体肿瘤;Review;血液肿瘤<br>经验分享:一审一个月,大修一个半月,小修后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Fri Feb 04 13:51:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:血液;肿瘤;综述<br>经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,<br>2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。<br>终于在2023.09.12 accept。<br>总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=800917, encodeId=5ee580091e3a, content=审稿速度:6.0<br>偏重的研究方向:血液学<br>经验分享:审稿时间大概五个月,提了很多问题很详细,大修一个月,接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200702/284aa92a2ae34578ae5df1f807e3678b/43c408bf15664b3ba10dcb5b02244935.jpg, createdBy=b9431973006, createdName=怕种菜, createdTime=Thu Jul 02 18:05:59 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799445, encodeId=5f1ae99445a7, content=去年中了一篇,先大修再小修,审稿人非常nice,但是整个过程时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=784b2053516, createdName=Lynn0123, createdTime=Tue Jun 23 13:17:02 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor一个月、催稿两次,目前还没有消息,服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向:肿瘤<br>经验分享:12月15日投稿,到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向:肿瘤;胃癌<br>经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2119068, encodeId=38ec21190682d, content=偏重的研究方向:review<br>经验分享:投稿几天后With editor 变成 Decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/eaf6a670992538bfff9986e52fed6975.jpg, createdBy=10022477991, createdName=羽翼纷飞, createdTime=Sun Mar 12 13:44:11 CST 2023, time=2023-03-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1087157, encodeId=f839108e15788, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2020-07-02 怕种菜

    审稿速度:6.0
    偏重的研究方向:血液学
    经验分享:审稿时间大概五个月,提了很多问题很详细,大修一个月,接收。

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1070637, encodeId=ddf910e063721, content=投稿命中率:25.0<br>经验分享:投稿第二天就显示under review ,是真的送审了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Tue Nov 16 08:24:15 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190139, encodeId=f2811190139c0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:实体肿瘤;Review;血液肿瘤<br>经验分享:一审一个月,大修一个半月,小修后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Fri Feb 04 13:51:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:血液;肿瘤;综述<br>经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,<br>2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。<br>终于在2023.09.12 accept。<br>总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=800917, encodeId=5ee580091e3a, content=审稿速度:6.0<br>偏重的研究方向:血液学<br>经验分享:审稿时间大概五个月,提了很多问题很详细,大修一个月,接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200702/284aa92a2ae34578ae5df1f807e3678b/43c408bf15664b3ba10dcb5b02244935.jpg, createdBy=b9431973006, createdName=怕种菜, createdTime=Thu Jul 02 18:05:59 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799445, encodeId=5f1ae99445a7, content=去年中了一篇,先大修再小修,审稿人非常nice,但是整个过程时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=784b2053516, createdName=Lynn0123, createdTime=Tue Jun 23 13:17:02 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor一个月、催稿两次,目前还没有消息,服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向:肿瘤<br>经验分享:12月15日投稿,到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向:肿瘤;胃癌<br>经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2119068, encodeId=38ec21190682d, content=偏重的研究方向:review<br>经验分享:投稿几天后With editor 变成 Decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/eaf6a670992538bfff9986e52fed6975.jpg, createdBy=10022477991, createdName=羽翼纷飞, createdTime=Sun Mar 12 13:44:11 CST 2023, time=2023-03-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1087157, encodeId=f839108e15788, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2020-06-23 Lynn0123

    去年中了一篇,先大修再小修,审稿人非常nice,但是整个过程时间很长

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1070637, encodeId=ddf910e063721, content=投稿命中率:25.0<br>经验分享:投稿第二天就显示under review ,是真的送审了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Tue Nov 16 08:24:15 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190139, encodeId=f2811190139c0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:实体肿瘤;Review;血液肿瘤<br>经验分享:一审一个月,大修一个半月,小修后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Fri Feb 04 13:51:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:血液;肿瘤;综述<br>经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,<br>2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。<br>终于在2023.09.12 accept。<br>总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=800917, encodeId=5ee580091e3a, content=审稿速度:6.0<br>偏重的研究方向:血液学<br>经验分享:审稿时间大概五个月,提了很多问题很详细,大修一个月,接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200702/284aa92a2ae34578ae5df1f807e3678b/43c408bf15664b3ba10dcb5b02244935.jpg, createdBy=b9431973006, createdName=怕种菜, createdTime=Thu Jul 02 18:05:59 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799445, encodeId=5f1ae99445a7, content=去年中了一篇,先大修再小修,审稿人非常nice,但是整个过程时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=784b2053516, createdName=Lynn0123, createdTime=Tue Jun 23 13:17:02 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor一个月、催稿两次,目前还没有消息,服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向:肿瘤<br>经验分享:12月15日投稿,到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向:肿瘤;胃癌<br>经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2119068, encodeId=38ec21190682d, content=偏重的研究方向:review<br>经验分享:投稿几天后With editor 变成 Decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/eaf6a670992538bfff9986e52fed6975.jpg, createdBy=10022477991, createdName=羽翼纷飞, createdTime=Sun Mar 12 13:44:11 CST 2023, time=2023-03-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1087157, encodeId=f839108e15788, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2023-10-18 ms7000000544050302 来自湖北省

    偏重的研究方向:综述;血液肿瘤
    经验分享:with editor一个月、催稿两次,目前还没有消息,服了。

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1070637, encodeId=ddf910e063721, content=投稿命中率:25.0<br>经验分享:投稿第二天就显示under review ,是真的送审了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Tue Nov 16 08:24:15 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190139, encodeId=f2811190139c0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:实体肿瘤;Review;血液肿瘤<br>经验分享:一审一个月,大修一个半月,小修后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Fri Feb 04 13:51:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:血液;肿瘤;综述<br>经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,<br>2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。<br>终于在2023.09.12 accept。<br>总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=800917, encodeId=5ee580091e3a, content=审稿速度:6.0<br>偏重的研究方向:血液学<br>经验分享:审稿时间大概五个月,提了很多问题很详细,大修一个月,接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200702/284aa92a2ae34578ae5df1f807e3678b/43c408bf15664b3ba10dcb5b02244935.jpg, createdBy=b9431973006, createdName=怕种菜, createdTime=Thu Jul 02 18:05:59 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799445, encodeId=5f1ae99445a7, content=去年中了一篇,先大修再小修,审稿人非常nice,但是整个过程时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=784b2053516, createdName=Lynn0123, createdTime=Tue Jun 23 13:17:02 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor一个月、催稿两次,目前还没有消息,服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向:肿瘤<br>经验分享:12月15日投稿,到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向:肿瘤;胃癌<br>经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2119068, encodeId=38ec21190682d, content=偏重的研究方向:review<br>经验分享:投稿几天后With editor 变成 Decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/eaf6a670992538bfff9986e52fed6975.jpg, createdBy=10022477991, createdName=羽翼纷飞, createdTime=Sun Mar 12 13:44:11 CST 2023, time=2023-03-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1087157, encodeId=f839108e15788, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2024-01-31 ms2000000592007598 来自浙江省

    偏重的研究方向:肿瘤
    经验分享:12月15日投稿,到现在还是with editor

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1070637, encodeId=ddf910e063721, content=投稿命中率:25.0<br>经验分享:投稿第二天就显示under review ,是真的送审了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Tue Nov 16 08:24:15 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190139, encodeId=f2811190139c0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:实体肿瘤;Review;血液肿瘤<br>经验分享:一审一个月,大修一个半月,小修后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Fri Feb 04 13:51:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:血液;肿瘤;综述<br>经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,<br>2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。<br>终于在2023.09.12 accept。<br>总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=800917, encodeId=5ee580091e3a, content=审稿速度:6.0<br>偏重的研究方向:血液学<br>经验分享:审稿时间大概五个月,提了很多问题很详细,大修一个月,接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200702/284aa92a2ae34578ae5df1f807e3678b/43c408bf15664b3ba10dcb5b02244935.jpg, createdBy=b9431973006, createdName=怕种菜, createdTime=Thu Jul 02 18:05:59 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799445, encodeId=5f1ae99445a7, content=去年中了一篇,先大修再小修,审稿人非常nice,但是整个过程时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=784b2053516, createdName=Lynn0123, createdTime=Tue Jun 23 13:17:02 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor一个月、催稿两次,目前还没有消息,服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向:肿瘤<br>经验分享:12月15日投稿,到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向:肿瘤;胃癌<br>经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2119068, encodeId=38ec21190682d, content=偏重的研究方向:review<br>经验分享:投稿几天后With editor 变成 Decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/eaf6a670992538bfff9986e52fed6975.jpg, createdBy=10022477991, createdName=羽翼纷飞, createdTime=Sun Mar 12 13:44:11 CST 2023, time=2023-03-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1087157, encodeId=f839108e15788, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2023-07-04 ms2000002077912665 来自北京

    偏重的研究方向:肿瘤;胃癌
    经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1070637, encodeId=ddf910e063721, content=投稿命中率:25.0<br>经验分享:投稿第二天就显示under review ,是真的送审了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Tue Nov 16 08:24:15 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190139, encodeId=f2811190139c0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:实体肿瘤;Review;血液肿瘤<br>经验分享:一审一个月,大修一个半月,小修后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Fri Feb 04 13:51:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:血液;肿瘤;综述<br>经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,<br>2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。<br>终于在2023.09.12 accept。<br>总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=800917, encodeId=5ee580091e3a, content=审稿速度:6.0<br>偏重的研究方向:血液学<br>经验分享:审稿时间大概五个月,提了很多问题很详细,大修一个月,接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200702/284aa92a2ae34578ae5df1f807e3678b/43c408bf15664b3ba10dcb5b02244935.jpg, createdBy=b9431973006, createdName=怕种菜, createdTime=Thu Jul 02 18:05:59 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799445, encodeId=5f1ae99445a7, content=去年中了一篇,先大修再小修,审稿人非常nice,但是整个过程时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=784b2053516, createdName=Lynn0123, createdTime=Tue Jun 23 13:17:02 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor一个月、催稿两次,目前还没有消息,服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向:肿瘤<br>经验分享:12月15日投稿,到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向:肿瘤;胃癌<br>经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2119068, encodeId=38ec21190682d, content=偏重的研究方向:review<br>经验分享:投稿几天后With editor 变成 Decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/eaf6a670992538bfff9986e52fed6975.jpg, createdBy=10022477991, createdName=羽翼纷飞, createdTime=Sun Mar 12 13:44:11 CST 2023, time=2023-03-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1087157, encodeId=f839108e15788, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2023-03-12 羽翼纷飞 来自重庆

    偏重的研究方向:review
    经验分享:投稿几天后With editor 变成 Decision in process

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1070637, encodeId=ddf910e063721, content=投稿命中率:25.0<br>经验分享:投稿第二天就显示under review ,是真的送审了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Tue Nov 16 08:24:15 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190139, encodeId=f2811190139c0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:实体肿瘤;Review;血液肿瘤<br>经验分享:一审一个月,大修一个半月,小修后就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201116/55827511442747d6a2c4eddf1b90c605/90d61936952348a1809c9ff037c4101f.jpg, createdBy=d5bb5260460, createdName=capoex, createdTime=Fri Feb 04 13:51:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157603, encodeId=8c04215e603fa, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:血液;肿瘤;综述<br>经验分享:2023.05.26投稿,3天后with editor,过了半个月还是with editor,于是发邮件催了一下,<br>2023.06.18 under review, 过了两个月还是没音信,就又催杂志社,没回应,本着破罐子破摔的想法,催了主编,没想到很快就给了小修(08.22),08.28返修回去,又是一直with editor,半个月后,还是with editor,等不及,又催了编辑,没反应,再催主编。<br>终于在2023.09.12 accept。<br>总结一下,这个杂志社只收综述,而且整个过程会很慢,编辑很不负责。自行考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Wed Sep 13 23:12:31 CST 2023, time=2023-09-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=800917, encodeId=5ee580091e3a, content=审稿速度:6.0<br>偏重的研究方向:血液学<br>经验分享:审稿时间大概五个月,提了很多问题很详细,大修一个月,接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200702/284aa92a2ae34578ae5df1f807e3678b/43c408bf15664b3ba10dcb5b02244935.jpg, createdBy=b9431973006, createdName=怕种菜, createdTime=Thu Jul 02 18:05:59 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799445, encodeId=5f1ae99445a7, content=去年中了一篇,先大修再小修,审稿人非常nice,但是整个过程时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=784b2053516, createdName=Lynn0123, createdTime=Tue Jun 23 13:17:02 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163619, encodeId=549f2163619a6, content=偏重的研究方向:综述;血液肿瘤<br>经验分享:with editor一个月、催稿两次,目前还没有消息,服了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d7b5481399, createdName=ms7000000544050302, createdTime=Wed Oct 18 21:31:13 CST 2023, time=2023-10-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185012, encodeId=7853218501278, content=偏重的研究方向:肿瘤<br>经验分享:12月15日投稿,到现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d018496553, createdName=ms2000000592007598, createdTime=Wed Jan 31 10:22:06 CST 2024, time=2024-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2146305, encodeId=f3e32146305b6, content=偏重的研究方向:肿瘤;胃癌<br>经验分享:7.1投了一篇网状meta,7.2 with editor,持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 04 17:13:34 CST 2023, time=2023-07-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2119068, encodeId=38ec21190682d, content=偏重的研究方向:review<br>经验分享:投稿几天后With editor 变成 Decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/eaf6a670992538bfff9986e52fed6975.jpg, createdBy=10022477991, createdName=羽翼纷飞, createdTime=Sun Mar 12 13:44:11 CST 2023, time=2023-03-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1087157, encodeId=f839108e15788, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 msSSSSSD

    讨论中局限性怎么撰写?

    1

    展开1条回复
共68条页码: 1/7页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分